Related Experiment Video
Updated: May 8, 2026

A Proinflammatory, Degenerative Organ Culture Model to Simulate Early-Stage Intervertebral Disc Disease.
Published on: February 14, 2021
Do microenvironmental changes in degenerative disc disease reflect in systemic circulation? A proteomic investigation
Sharon Miracle Nayagam1, Narmatha Devi Palraj1, Murugesh Eswaran1
1Ganga Research Center, Ganga Orthopedic Research abd Education Foundation, 91, Mettupalayam Road, Coimbatore, 30, India.
Insights
Systemic complement alterations are present in degenerative disc disease (DDD) plasma, suggesting potential blood-based biomarkers for localized disc pathology. Further research is needed to explore their diagnostic and therapeutic implications.
Area of Science:
- Immunology
- Proteomics
- Biochemistry
Background:
- The complement system is integral to immune regulation and inflammation, implicated in intervertebral disc degeneration (IDD).
- While local complement activation in degenerated discs is known, systemic complement expression in degenerative disc disease (DDD) plasma is not well understood.
Purpose of the Study:
- To investigate systemic complement protein expression in the plasma of patients with degenerative disc disease (DDD).
- To explore the potential of plasma complement proteins as blood-based biomarkers for DDD.
Main Methods:
- High-throughput mass spectrometry was used to analyze plasma proteomes from 40 DDD patients (Modic change and non-Modic change) and 20 healthy volunteers.
- Proteomic data were analyzed to identify differentially expressed complement proteins and assess correlations with systemic inflammation markers like C-reactive protein (CRP).
Main Results:
- Proteomic analysis identified significant differences in plasma protein profiles between DDD patients and healthy volunteers, with enrichment of complement and coagulation cascades.
- Most complement proteins were upregulated in DDD plasma, with notable exceptions including C1q complex and Complement Factor D (CFD).
- Elevated C-reactive protein (CRP) levels in DDD plasma indicated systemic inflammation, though correlations between plasma and tissue complement levels were weak.
Conclusions:
- Systemic complement alterations in DDD plasma suggest their potential utility as blood-based biomarkers reflecting localized disc pathology.
- Further validation in larger, diverse cohorts is required to establish the diagnostic and therapeutic significance of these findings.
- The study provides a foundation for developing novel diagnostic tools and therapeutic strategies for DDD.
Background:
The complement system plays a crucial role in immune regulation and inflammation, contributing to intervertebral disc degeneration (IDD) pathogenesis. While tissue-specific complement activation in degenerated discs is well-documented, its systemic expression in degenerative disc disease (DDD) plasma remains unclear.
Methods:
This study employed high-throughput mass spectrometry to analyze the plasma and tissue proteomes of 40 DDD patients, comprising of Modic change (MC) and non-Modic change (NMC) patients, alongside 20 healthy volunteers (HV). Only plasma and no plasma-matched tissue samples were collected from HV group.
Results:
Proteomic analysis identified 707 proteins in DDD plasma and 655 in HV plasma, with 508 common. Complement and coagulation cascades were enriched, with 46 complement proteins identified. The DDD-plasma group exhibited upregulation of most complement proteins, except for C1q complex (1.38-fold) and Complement Factor D (CFD, 0.64-fold), alongside slight downregulation of vitronectin (VTN), clusterin (CLU), and complement C8G. Elevated C-reactive protein (CRP) levels were observed in DDD-plasma, indicating systemic inflammation. Correlation analysis revealed weak associations between plasma and tissue complement protein levels, suggesting potential regulatory mechanisms.
Conclusion:
Our study reveals that systemic complement alterations in DDD, supporting their potential as blood-based biomarkers reflecting localized disc pathology. Further validation in larger cohorts across different disease stages is needed to explore their diagnostic and therapeutic implications. Data are available via ProteomeXchange with identifier PXD063403.
More Related Videos
Related Concept Videos
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Degenerative Disc Disease I: Introduction
Degenerative Disc Disease ll: Pathophysiology

